Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Qualigen Therapeutics stock

Learn how to easily invest in Qualigen Therapeutics stock.

Qualigen Therapeutics Inc is a biotechnology business based in the US. Qualigen Therapeutics shares (QLGN) are listed on the NASDAQ and all prices are listed in US Dollars. Qualigen Therapeutics employs 39 staff and has a trailing 12-month revenue of around $4.8 million.

How to buy shares in Qualigen Therapeutics

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – QLGN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Qualigen Therapeutics stock price (NASDAQ: QLGN)

Use our graph to track the performance of QLGN stocks over time.

Qualigen Therapeutics shares at a glance

Information last updated 2022-09-27.
Latest market close$0.27
52-week range$0.26 - $3.12
50-day moving average $0.39
200-day moving average $0.63
Wall St. target price$4.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.55

Buy Qualigen Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Qualigen Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Qualigen Therapeutics price performance over time

Historical closes compared with the close of $0.267 from 2022-09-30

1 week (2022-09-22) -4.91%
1 month (2022-08-30) N/A
3 months (2022-06-30) -53.16%
6 months (2022-03-30) N/A
1 year (2021-10-01) -79.30%
2 years (2020-10-02) -94.41%
3 years (2019-10-03) 0.2679
5 years (2017-10-03) 0.3638

Qualigen Therapeutics financials

Revenue TTM $4.8 million
Gross profit TTM $-4,795,478
Return on assets TTM -35.16%
Return on equity TTM -102.2%
Profit margin 0%
Book value $0.37
Market capitalisation $11.1 million

TTM: trailing 12 months

Qualigen Therapeutics share dividends

We're not expecting Qualigen Therapeutics to pay a dividend over the next 12 months.

Have Qualigen Therapeutics's shares ever split?

Qualigen Therapeutics's shares were split on a 1:25 basis on 26 May 2020. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Qualigen Therapeutics shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Qualigen Therapeutics shares which in turn could have impacted Qualigen Therapeutics's share price.

Qualigen Therapeutics share price volatility

Over the last 12 months, Qualigen Therapeutics's shares have ranged in value from as little as $0.26 up to $3.12. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Qualigen Therapeutics's is -0.1625. This would suggest that Qualigen Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Qualigen Therapeutics has bucked the trend.

Qualigen Therapeutics overview

Qualigen Therapeutics, Inc. , a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California. .

Frequently asked questions

What percentage of Qualigen Therapeutics is owned by insiders or institutions?
Currently 9.825% of Qualigen Therapeutics shares are held by insiders and 6.167% by institutions.
How many people work for Qualigen Therapeutics?
Latest data suggests 39 work at Qualigen Therapeutics.
When does the fiscal year end for Qualigen Therapeutics?
Qualigen Therapeutics's fiscal year ends in December.
Where is Qualigen Therapeutics based?
Qualigen Therapeutics's address is: 2042 Corte Del Nogal, Carlsbad, CA, United States, 92011
What is Qualigen Therapeutics's ISIN number?
Qualigen Therapeutics's international securities identification number is: US74754R1032

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site